Home
>
Pharmaceutical Intermediates
>
Bulk Drug Intermediates
>
B7-33 2mg/5mg/10mg
for Sale
>
B7-33 6mg Hot Selling B76 Factory Direct Supply Global Shipping Compound Raw Material
B7-33 6mg Hot Selling B76 Factory Direct Supply Global Shipping Compound Raw Material
3 Inquiries
CAS No.:
1818415-56-3
Grade:
Pharmaceutical Grade
Content:
99%
Port:
Guangdong
Brand:
Beautide
Packaging:
10vials/box
Price valid (until):
2027-01-31
Company Type:
Trader
Location:
China
Qualification:
Main Products:
Peptide Products
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceB7-33 is a selective relaxin receptor 1 (RXFP1) agonist. It binds to RXFP1 and preferentially activates thepERK pathway over cAMP in cells (with RXFP1 expression).Basic Info
-
Product Name:
B7-33 2mg/5mg/10mg
Other Name:B7-33 2mg/5mg/10mg;L-Leucinamide, L-valyl-L-isoleucyl-L-lysyl-L-leucyl-L-serylglycyl-L-arginyl-L-α-glutamyl-L-leucyl-L-valyl-L-arginyl-L-alanyl-L-glutaminyl-L-isoleucyl-L-alanyl-L-isoleucyl-L-serylglycyl-L-methionyl-L-seryl-L-threonyl-L-tryptophyl-L-seryl-L-lysyl-L-arginyl-L-seryl-;(B7-33)H2;B7-33 relaxin
CAS No.:1818415-56-3
Molecular Formula:C131H229N41O36S
Molecular Weight:2986.54
Categories:
Characteristics-
Density:
1.445±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptide Products
-
Location:
Unit 1262, Room 103, Building Jia-19, Jixiangyuan, Tongzhou District, Beijing
-
Payment Terms:
100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
11-50
-
Year of Establishment:
2026
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted 
United Kingdom
B7-33
360 MG May 10, 2026 
Canada
B7-33
1 Aug 13, 2026 
United States
B7-33
200 MG Aug 13, 2025 Post an enquiry for this product
